Valuation Trading Multiples & Precedent Transactions: Pharma Packaging and Medical Consumables Companies
Valuation benchmarks for Pharma Packaging and Medical Consumables Companies. Access public trading comps, EV/EBITDA acquisition multiples, and private market data for pitch books and valuation analysis.
1.1 - Pharma Packaging and Medical Consumables Companies Market Context & Valuation Drivers
Companies in this public trading comparables group manufacture and supply disposable medical consumables and pharmaceutical drug‑delivery packaging used across acute and chronic care. Core models center on high‑volume, recurring sales of syringes, needles, IV solutions, dialysis disposables, and sterile containment systems for injectable therapies. They are comparable based on regulated manufacturing, quality systems, long‑term supply contracts, and exposure to procedure, prescription, and patient‑treatment volumes.
Typical capabilities include designing and producing prefillable syringes, cartridges, vials, and ampoules, manufacturing hypodermic needles and disposable syringes, and developing self‑injection and drug‑delivery devices. Many provide IV therapy solutions and non‑PVC bags, dialysis consumables such as dialyzers and dialysate, sterile containment and closure systems, specialty diagnostics and lab consumables, and water purification systems, supported by GMP compliance, sterilization expertise, materials science, and global distribution.
Primary customers include biopharmaceutical manufacturers, hospitals and health systems, outpatient clinics, dialysis providers, and clinical laboratories. Valuation benchmarks emphasize recurring consumable pull‑through, revenue growth tied to procedure and prescription volumes, gross margin resilience driven by product mix and pricing, contract retention and share‑of‑wallet with strategic accounts, and EBITDA and free‑cash‑flow conversion supported by efficient regulated production and capacity utilization.
2. Valuation Analysis: Public Trading Comps & Multiples for Pharma Packaging and Medical Consumables Companies companies
2.1 - Public Peer Groups & Median Valuation Multiples for Pharma Packaging and Medical Consumables Companies sector
Comparable group 1: Pharma Packaging and Medical Consumables Companies
Kelun
- Enterprise value: $●●●m
- Market Cap: $●●●m
- EV/Revenue: ●.●x
- EV/EBITDA: ●●.●x
- Description: Provider of pharmaceutical and healthcare products including innovative drug development with expertise in antibody-drug conjugate (ADC) technology for enhanced precision in targeting and delivery of therapeutic agents.
- Key Products:
- Innovative Drugs: Development and commercialization of innovative therapeutic products with a focus on treating complex diseases
- Antibody Drug Conjugates: Specializes in creating ADCs that enhance precision in targeting and delivery of anticancer agents
- Integrated Drug Development: Provides a comprehensive platform for research, development, manufacturing, and commercialization of medicines
- Clinical Research: Offers advanced facilities and platforms for clinical research and trials
- Global Strategic Partnerships: Engages in collaborations with multinational pharmaceutical firms to foster innovation and scalable growth.
Fresenius
- Enterprise value: $●●●m
- Market Cap: $●●●m
- EV/Revenue: ●.●x
- EV/EBITDA: ●●.●x
- Description: Provider of healthcare products and services, specializing in dialysis, hospitals, and outpatient medical care, offering innovative and accessible healthcare solutions to critically and chronically ill patients worldwide.
- Key Products:
- Dialysis Products: Equipment and supplies for dialysis treatment
- Hospital Management: Comprehensive management and operation of hospitals
- Outpatient Care: Medical services provided outside hospital settings
- Pharmaceuticals: Specialty pharmaceuticals and IV drugs for acute and chronic patients
- Medical Devices: Devices and technologies for various medical applications